These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 6335071

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. 1-Deamino-8-D-arginine-vasopressin--an alternative in the management of mild haemophilia A and von Willebrand's disease.
    Niessner H, Korninger C.
    Wien Klin Wochenschr; 1983 Nov 11; 95(21):753-7. PubMed ID: 6424339
    [Abstract] [Full Text] [Related]

  • 3. [Intravenous administration of deamino-D-arginine-vasopressin (DDAVP) to patients with hemophilia A and von Willebrand's disease].
    Janczarski M, Ruszkowska I, Cetnarowicz H, Lopaciuk S.
    Acta Haematol Pol; 1990 Nov 11; 21(1):16-21. PubMed ID: 2260405
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Desamino-8-D-arginine vasopressin nose drops in the treatment of mild hemophilia A and von Willebrand's disease].
    Streit A, Furlan M, Beck EA.
    Schweiz Med Wochenschr; 1984 Oct 06; 114(40):1389-91. PubMed ID: 6333722
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prospective multicenter study on subcutaneous concentrated desmopressin for home treatment of patients with von Willebrand disease and mild or moderate hemophilia A.
    Rodeghiero F, Castaman G, Mannucci PM.
    Thromb Haemost; 1996 Nov 06; 76(5):692-6. PubMed ID: 8950775
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the effectiveness of DDAVP in surgery and in bleeding episodes in haemophilia and von Willebrand's disease. A study on 43 patients.
    Mariana G, Ciavarella N, Mazzucconi MG, Antoncecchi S, Solinas S, Ranieri P, Pettini P, Agrestini F, Mandelli F.
    Clin Lab Haematol; 1984 Nov 06; 6(3):229-38. PubMed ID: 6440729
    [Abstract] [Full Text] [Related]

  • 9. Von Willebrand disease within the collective of haemophilic patients as reason for unexpected bleeding episodes.
    Siegmund B, Richter H, Pollmann H.
    Haemophilia; 2007 Jan 06; 13(1):21-5. PubMed ID: 17212720
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. DDAVP in haemophilia and von Willebrand's disease.
    Lancet; 1983 Oct 01; 2(8353):774-5. PubMed ID: 6137606
    [No Abstract] [Full Text] [Related]

  • 12. Haemostatic management of intraoral bleeding in patients with von Willebrand disease.
    Morimoto Y, Yoshioka A, Sugimoto M, Imai Y, Kirita T.
    Oral Dis; 2005 Jul 01; 11(4):243-8. PubMed ID: 15984956
    [Abstract] [Full Text] [Related]

  • 13. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ, van Vliet HH, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van der Velden A, Budde U.
    Clin Appl Thromb Hemost; 2007 Jan 01; 13(1):14-34. PubMed ID: 17164493
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of hemophilia A and von Willebrand's disease with 1-deamino-8-D-arginine vasopressin (DDAVP). Hemophilia and DDAVP].
    Ingerslev J, Christiansen SE, Kristensen T, Wallevik K, Bernvil SS.
    Ugeskr Laeger; 1985 Nov 04; 147(45):3592-4. PubMed ID: 3907076
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical application of new synthetic vasopressin 1-deamino-8-D-arginine vasopressin (DDAVP): hemostatic control of von Willebrand's disease (author's transl)].
    Kobayashi I, Takahashi H, Sanada M, Takahashi K, Hattori A, Ito M, Sakuragawa N, Shibata A, Shinada S, Tsukada T.
    Rinsho Ketsueki; 1979 Apr 04; 20(4):364-71. PubMed ID: 312954
    [No Abstract] [Full Text] [Related]

  • 16. The natural history of hepatitis C virus infection in Italian patients with von Willebrand's disease: a cohort study.
    Federici AB, Santagostino E, Rumi MG, Russo A, Mancuso ME, Soffredini R, Mannucci PM, Colombo M.
    Haematologica; 2006 Apr 04; 91(4):503-8. PubMed ID: 16585016
    [Abstract] [Full Text] [Related]

  • 17. Combined haemophilia A and type I von Willebrand's disease: a family study including an evaluation of the effects of DDAVP infusion.
    Casonato A, Pontara E, Boscaro M, Dannhauser D, Sartori MT, Girolami A.
    Haematologia (Budap); 1993 Apr 04; 25(1):57-67. PubMed ID: 8339998
    [Abstract] [Full Text] [Related]

  • 18. Beneficial effect of D.D.A.V.P. on bleeding-time in von Willebrand's disease.
    Menon C, Berry EW, Ockelford P.
    Lancet; 1978 Sep 30; 2(8092 Pt 1):743-4. PubMed ID: 80674
    [No Abstract] [Full Text] [Related]

  • 19. Clinical evaluation of subcutaneously administered DDAVP.
    Ghirardini A, Chistolini A, Tirindelli MC, Di Paolantonio T, Iacopino G, Mariani P, Chirletti P, Agrestini F, Mariani G.
    Thromb Res; 1988 Feb 01; 49(3):363-72. PubMed ID: 3259021
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.